Last reviewed · How we verify
breast lesions
Approved treatments
- Technetium Tc 99M Sestamibi · Cyclomedica
Technetium Tc 99m Sestamibi accumulates in viable myocardial tissue similar to thallous chloride TI-201, with possible mitochondrial retention.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- breast lesions patent landscape — cliff calendar, originator estates, attackable patents
- breast lesions treatment landscape brief
- breast lesions treatment updates RSS
Frequently asked questions about breast lesions
What drugs treat breast lesions?
Tracked treatments include Technetium Tc 99M Sestamibi.
What is the treatment for breast lesions?
Standard treatment for breast lesions includes Technetium Tc 99M Sestamibi. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: breast lesions patent cliff · breast lesions CI report
- Treatment: Technetium Tc 99M Sestamibi · Cyclomedica
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing